Global Syphilis Testing Market Size Exceed To USD 2.44 Billion by 2035| CAGR of 5.46% : Industry Analysis Report

• As per Spherical Insights & Consulting, The Global Syphilis Testing Market Size is expected to Grow from USD 1.36 Billion in 2024 to USD 2.44 Billion by 2035, at a CAGR of 5.46% during the forecast period 2025-2035, owing to the launch of new therapies in the market and the rise in the number of cases.

 

• The leading Syphilis Testing Market Companies such as PerkinElmer, QuidelOrtho, Roche Diagnostics, BD (Becton Dickinson), Qiagen, OraSure Technologies, Siemens Healthineers, Bio-Rad Laboratories, Thermo Fisher Scientific, Cepheid, Hologic, Cardinal Health, Abbott Laboratories, bioMérieux, Danaher Corporation, and Others.

 

 

Syphilis Testing Treatment Market: Understanding and Treatment Algorithm:

Syphilis is an infectious sexually transmitted infection caused by bacterial traponima palidum. It progresses in stages and can cause serious health problems when untreated. Early detection and treatment are necessary to prevent complications and prevent its spread for others.

 

Syphilis Testing Diagnosis:

Diagnosis of syphilis through blood tests that detect antibodies against infection along with physical examination and patient history also helps. In some cases, samples of wounds or wounds are tested. Initial diagnosis is important to quickly start treatment and avoid serious health issues.

 

Syphilis Testing Treatment:

Syphilis is usually treated with antibiotics, most penicillin. Treatment depends on the phase of infection and the patient health. The syphilis of the initial stage can be easily cured, while prolonged treatment may be required in later stages. Prompt therapy helps others prevent long -term damage and transmission.

 

Syphilis Testing Epidemiology:

The disease epidemiology covered in the report provides historical as well as forecasted epidemiology segmented by Total Diagnosed Incident Population of Syphilis Testing, Gender specific Diagnosed Incidence of Syphilis Testing, Type specific Diagnosed Incidence of Syphilis Testing, Age specific Diagnosed Incidence of Syphilis Testing, Diagnosed Incident Population based on Primary Site of Syphilis Testing, and Diagnosed Incident Population based on Histologic Classification of Syphilis Testing Tumour in the global market covering North America, Europe, Asia-Pacific, Latin America, the Middle East, and Africa from 2024 to 2035.

 

Principal Insights:

This section offers a global overview of syphilis testing epidemiology in major markets worldwide.

 

Country Wise Syphilis Testing Multiforme Epidemiology:

• The epidemiology segment provides Syphilis Testing prevalence data and findings across key regions worldwide, including North America, Europe (Germany, France, Italy, Spain, and the United Kingdom), Asia-Pacific (including Japan), Latin America, the Middle East, and Africa.

 

Syphilis Testing Recent Developments:

• In February 2023, NOWDiagnostics announced the launch of First to Know Syphilis Test, marking the first FDA-cleared over-the-ounter, at-home rapid test for syphilis. The test provided results in about 15 minutes from a small blood sample and became available nationwide through major retailers and public health channels.

 

Syphilis Testing Marketed Drugs:

•            Bicillin L-A: Pfizer

Bicillin L-A (benzathine penicillin G) is a long-acting antibiotic used as the first-line treatment for all stages of syphilis. It works by killing Treponema pallidum, the bacteria responsible for syphilis. It is administered via intramuscular injection and is FDA-approved for treating primary, secondary, and latent syphilis.

 

•            Doxycycline: Teva Pharmaceuticals

Doxycycline is a tetracycline antibiotic used as an alternative treatment for syphilis, especially in patients allergic to penicillin. It inhibits bacterial protein synthesis, halting the growth of Treponema pallidum. Although not the first-line therapy, it is widely prescribed for early-stage syphilis in penicillin-intolerant patients.

 

Syphilis Testing: Emerging Therapies:

• TrepoDx: It is a molecular diagnostic platform in late stage trials for syphilis testing. It uses real time PCR to detect Treponema pallidum DNA with high sensitivity, aiming to enable early and accurate diagnosis, especially in asymptomatic or latent cases where traditional serology may fall short.

 

• SYP-Clear: It is an advanced point of care immunoassay under development for rapid syphilis detection. It targets specific treponemal antibodies using enhanced signal amplification, aiming to deliver accurate results in under 15 minutes, improving diagnosis in low-resource and remote settings.

 

Syphilis Testing Market Outlook:

• The Syphilis Testing market involves diagnostic tools and technologies designed to detect Treponema pallidum, the bacterium causing syphilis. It includes laboratory based and point of care tests that enable early and accurate detection, helping reduce disease transmission and guide effective treatment.

 

• Rising global prevalence of syphilis, increasing awareness about sexually transmitted infections, and demand for rapid, accurate diagnostics drive market growth. Additionally, expanding healthcare infrastructure and technological advancements in point of care testing contribute to enhanced screening and early disease management.

 

• Growing adoption of multiplex testing panels, increasing demand for at home and point of care syphilis tests, and expansion in emerging markets present significant opportunities. Advances in molecular diagnostics and government-backed screening programs further propel market potential.

 

• Governments worldwide have launched awareness campaigns, screening programs, and funding for STI control. Many support widespread syphilis testing via public health agencies and incentivize innovations in rapid and accessible diagnostic technologies to curb disease spread.

 

• Stigma and lack of awareness in some regions limit early testing and treatment adoption.

 

• The market is projected to grow steadily, driven by rising STI incidence and growing demand for convenient, rapid diagnostic solutions.

 

Syphilis Testing Market Segmentation:

By Type:

• Primary & Secondary Syphilis
• Others

 

 

The Primary & Secondary Syphilis segment holds the largest market share because these stages are the most infectious and commonly diagnosed. Early detection is critical for treatment and public health control, driving higher testing volumes. Increased awareness and routine STI screenings have made this segment the focus of diagnostic efforts.

 

By Location of Testing:

• Laboratory Testing
• Point of Care (POC) Testing

 

 

Laboratory Testing dominates the market due to its high accuracy, advanced diagnostic tools, and wide availability in healthcare settings. Hospitals and diagnostic labs prefer lab based methods like blood tests and treponemal or non-treponemal assays, which provide reliable results, especially in complex or asymptomatic cases, boosting their widespread use and market share.

 

Regional Segment Analysis of the Syphilis Testing Market:

North America holds the largest share in the syphilis testing market due to its advanced healthcare infrastructure, high public awareness, and strong government led STI screening programs. The region benefits from widespread access to laboratory diagnostics and early adoption of advanced testing technologies. Increased routine screening, especially among high risk populations, and efficient disease tracking systems contribute significantly to the region’s dominant position in the global market.

 

Asia Pacific is the fastest growing region in the syphilis testing market, driven by rising STI prevalence, improving healthcare access, and growing awareness initiatives. Developing nations within the region are increasing investments in public health and diagnostics. Expanding urban populations and efforts by governments and NGOs to promote early detection and treatment are accelerating market growth, especially in underserved and rural areas where point-of-care testing is gaining momentum.

 

Syphilis Testing Market Key Companies:

• PerkinElmer
• QuidelOrtho
• Roche Diagnostics
• BD (Becton Dickinson)
• Qiagen
• OraSure Technologies
• Siemens Healthineers
• Bio-Rad Laboratories
• Thermo Fisher Scientific
• Cepheid
• Hologic
• Cardinal Health
• Abbott Laboratories
• BioMérieux
• Danaher Corporation
• Others

 

Syphilis Testing Therapeutics Market Report Scope:

• The Syphilis Testing therapeutics market report provides a detailed overview, covering its causes, symptoms, disease progression, and existing treatment options.

 

• Detailed insights into Syphilis Testing’s epidemiology and therapeutic approaches are included.

 

• Additionally, a comprehensive review of existing and emerging Syphilis Testing therapies is provided, including an evaluation of new treatments expected to influence the current Syphilis Testing treatment market landscape.

 

• The report includes a detailed review of the Syphilis Testing therapeutics market, both historical and forecasted, highlighting the global drug reach.

 

• The Patient-Based Syphilis Testing Market Forecasting report offers valuable insights into trends shaping the global Syphilis Testing market, helping to develop effective business strategies.

 

Syphilis Testing Treatment Market Report Insights:

• Forecasting Market Trends Based on Patient Data and Disease Rates
• Syphilis Testing Therapeutic Approaches in Syphilis Testing
• Review Of Drugs in Development for Syphilis Testing
• Market, Growth, and Trends in Syphilis Testing
• Market Opportunities in Syphilis Testing Treatment
• Effects Of Future Therapies on Syphilis Testing Treatment.

 

Syphilis Testing Treatment Market Report Key Strengths

• 15 Years Syphilis Testing Market Forecast
• Global Coverage
• Syphilis Testing Epidemiology Segmentation
• Key Cross Competition

 

Syphilis Testing Treatment Market Report Assessment

• Present Practices in the Syphilis Testing Treatment Market
• Review of Investigational Syphilis Testing Drugs
• Attractiveness of the Syphilis Testing Drug Market
• Syphilis Testing Market Drivers
• Syphilis Testing Market Barriers
• SWOT
• Attribute Analysis

 

Market Segment:

This study forecasts revenue at the global, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the syphilis testing market based on the below mentioned segments:

 

Global Syphilis Testing Market, By Type

• Primary & Secondary Syphilis
• Others

 

Global Syphilis Testing Market, By Location of Testing

• Laboratory Testing
• Point of Care (POC) Testing

 

Global Syphilis Testing Market, By Regional Analysis

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa